| Today's Open | $3.05 |
|---|---|
| Previous Close | $3.05 |
| Daily Range | $3.00 - $3.06 |
| 52-Week Range | $2.26 - $5.00 |
| Market Cap | $178.8M |
| P/E Ratio | -8.47 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 116,712 |
| Average Daily Volume | 135,679 |
| Current FY EPS | -$0.37 |
Sector
Healthcare
Industry
Drugs
PLURISTEM THERAPEUTICS, INC. (PSTI) Description
Pluristem Therapeutic is a bio-therapeutics Company dedicated to the commercialization of non-personalized cell therapy products for the treatment of several severe degenerative ischemic and autoimmune disorders. Website: http://www.pluristem.com/
News & Commentary
Pluristem Gets FDA's Orphan Drug Nod for Anemia Treatment
Seven-year window of exclusivity, tax credits among benefits upon drug approval.United Therapeutics Receives Regulatory Approval to Commence Phase I Study of Pluristem's PLX-PAD Ce
United Therapeutics Receives Regulatory Approval to Commence Phase I Study of Pluristem's PLX-PAD Cells for Pulmonary Arterial HypertensionPipeline Progress at Pluristem - Analyst Blog
Pipeline Progress at Pluristem - Analyst BlogPSTI's Top Competitors
(0.00%)
(0.63%)
(2.44%)
(-0.50%)